Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1920 1
1946 5
1947 1
1948 1
1949 2
1950 3
1951 2
1952 4
1953 6
1954 5
1955 6
1956 7
1957 5
1958 3
1959 4
1960 3
1961 7
1962 3
1963 7
1964 8
1965 8
1966 14
1967 12
1968 27
1969 21
1970 13
1971 14
1972 20
1973 25
1974 23
1975 13
1976 15
1977 7
1978 13
1979 18
1980 14
1981 10
1982 15
1983 13
1984 13
1985 14
1986 19
1987 17
1988 21
1989 21
1990 21
1991 33
1992 24
1993 23
1994 39
1995 44
1996 37
1997 47
1998 48
1999 49
2000 67
2001 61
2002 65
2003 60
2004 70
2005 55
2006 59
2007 84
2008 93
2009 108
2010 105
2011 110
2012 154
2013 125
2014 137
2015 161
2016 164
2017 166
2018 158
2019 155
2020 163
2021 229
2022 209
2023 205
2024 85

Text availability

Article attribute

Article type

Publication date

Search Results

3,571 results

Results by year

Filters applied: . Clear all
Page 1
Genomic evidence for the widespread presence of GH45 cellulases among soil invertebrates.
Muelbaier H, Arthen F, Collins G, Hickler T, Hohberg K, Lehmitz R, Pauchet Y, Pfenninger M, Potapov A, Romahn J, Schaefer I, Scheu S, Schneider C, Ebersberger I, Bálint M. Muelbaier H, et al. Among authors: schneider c. Mol Ecol. 2024 May 7:e17351. doi: 10.1111/mec.17351. Online ahead of print. Mol Ecol. 2024. PMID: 38712904
IT-Related Barriers and Facilitators to the Implementation of a New European eHealth Solution, the Digital Survivorship Passport (SurPass Version 2.0): Semistructured Digital Survey.
de Beijer IAE, van den Oever SR, Charalambous E, Cangioli G, Balaguer J, Bardi E, Alfes M, Cañete Nieto A, Correcher M, Pinto da Costa T, Degelsegger-Márquez A, Düster V, Filbert AL, Grabow D, Gredinger G, Gsell H, Haupt R, van Helvoirt M, Ladenstein R, Langer T, Laschkolnig A, Muraca M, Pluijm SMF, Rascon J, Schreier G, Tomášikova Z, Trauner F, Trinkūnas J, Trunner K, Uyttebroeck A, Kremer LCM, van der Pal HJH, Chronaki C; PanCareSurPass Consortium. de Beijer IAE, et al. J Med Internet Res. 2024 May 2;26:e49910. doi: 10.2196/49910. J Med Internet Res. 2024. PMID: 38696248 Free article.
Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry.
Kutsch N, Giza A, Robrecht S, Stumpf J, Federhen A, Stoltefuß A, Vehling-Kaiser U, Koenigsmann M, Tausch E, Schneider C, Stilgenbauer S, Illmer T, Schlag R, Dörfel S, Gaska T, Kiehl M, Müller-Hagen S, Moorahrend E, Linde H, Schlenska-Lange A, von Tresckow J, Fischer K, Eichhorst B, Hallek M, Fink AM. Kutsch N, et al. Among authors: schneider c. Eur J Haematol. 2024 May 1. doi: 10.1111/ejh.14220. Online ahead of print. Eur J Haematol. 2024. PMID: 38693677
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.
Roessner PM, Seufert I, Chapaprieta V, Jayabalan R, Briesch H, Massoni-Badosa R, Boskovic P, Beckendorff J, Roider T, Arseni L, Coelho M, Chakraborty S, Vaca A, Sivina M, Muckenhuber M, Rodriguez-Rodriguez S, Bonato A, Herbst SA, Zapatka M, Sun C, Kretzmer H, Naake T, Bruch PM, Czernilofsky F, Ten Hacken E, Schneider M, Helm D, Yosifov DY, Kauer J, Danilov AV, Bewarder M, Heyne K, Schneider C, Stilgenbauer S, Wiestner A, Mallm JP, Burger JA, Efremov DG, Lichter P, Dietrich S, Martín-Subero JI, Rippe K, Seiffert M. Roessner PM, et al. Among authors: schneider c. Blood. 2024 Apr 29:blood.2023021990. doi: 10.1182/blood.2023021990. Online ahead of print. Blood. 2024. PMID: 38684038
A genome-first approach to variants in MLXIPL and their association with hepatic steatosis and plasma lipids.
Hehl L, Creasy KT, Vitali C, Scorletti E, Seeling KS, Vell MS, Rendel MD, Conlon D, Vujkovic M, Zandvakili I, Trautwein C, Schneider KM, Rader DJ, Schneider CV; Regeneron Genetics Center. Hehl L, et al. Among authors: schneider cv. Hepatol Commun. 2024 Apr 26;8(5):e0427. doi: 10.1097/HC9.0000000000000427. eCollection 2024 May 1. Hepatol Commun. 2024. PMID: 38668731 Free article.
3,571 results